<code id='30A08460E5'></code><style id='30A08460E5'></style>
    • <acronym id='30A08460E5'></acronym>
      <center id='30A08460E5'><center id='30A08460E5'><tfoot id='30A08460E5'></tfoot></center><abbr id='30A08460E5'><dir id='30A08460E5'><tfoot id='30A08460E5'></tfoot><noframes id='30A08460E5'>

    • <optgroup id='30A08460E5'><strike id='30A08460E5'><sup id='30A08460E5'></sup></strike><code id='30A08460E5'></code></optgroup>
        1. <b id='30A08460E5'><label id='30A08460E5'><select id='30A08460E5'><dt id='30A08460E5'><span id='30A08460E5'></span></dt></select></label></b><u id='30A08460E5'></u>
          <i id='30A08460E5'><strike id='30A08460E5'><tt id='30A08460E5'><pre id='30A08460E5'></pre></tt></strike></i>

          fashion

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Drug for rare kidney disease narrowly misses mark in clinical trial
          Drug for rare kidney disease narrowly misses mark in clinical trial

          AdobeTravereTherapeuticssaidThursdaythatastudymeanttoconfirmthebenefitofitsnewlyapproveddrugforarare

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          FDA panel to weigh approval of NurOwn, controversial ALS drug

          AdobeYearsofpolarizingscientificdiscourseandbruisingonlinedebatewillcometoaheadnextweekwhenadviserst